Zeki Topçu

738 citations
33 papers · 596 indexed · h-index 16
Topics
Cancer therapeutics and mechanisms (13 papers)Synthesis and biological activity (8 papers)Bioactive Compounds and Antitumor Agents (4 papers)

In The Last Decade

Zeki Topçu

32 papers receiving 577 citations

Peers

Zeki Topçu
Comparison fields: 5 of 77
  • Molecular Biology 334
  • Organic Chemistry 218
  • Physiology 73
  • Toxicology 57
  • Oncology 53
Replace Shoubin Tang with:
Shoubin Tang China
Rachel A. Jones United States
Prabhakar Risbood United States
Martin A. Read United Kingdom
Rohit Mahar India
James Luba United States
Helen Browne United Kingdom
Shuqiang Chen China
Mai E. Shoman Egypt
Sebastian Kehr Germany
Zeki Topçu relative to Shoubin Tang China Shoubin Tang's profile →
Citations per field
00.5×4.6×
Shoubin Tang · 1×
Citations per year

Countries citing papers authored by Zeki Topçu

Since Specialization
Citations

This map shows the geographic impact of Zeki Topçu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeki Topçu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeki Topçu more than expected).

Fields of papers citing papers by Zeki Topçu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeki Topçu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeki Topçu. The network helps show where Zeki Topçu may publish in the future.

Co-authorship network of co-authors of Zeki Topçu

This figure shows the co-authorship network connecting the top 25 collaborators of Zeki Topçu. A scholar is included among the top collaborators of Zeki Topçu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeki Topçu. Zeki Topçu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 2
4 5
5 3
6 32
7 4
8 5
9
The Effects of Arolycoricidine and Narciprimine on Tumor Cell Killing and Topoisomerase Activity
17
10 20
11 43
12
The mRNA expression of cytochrome P450 isoforms in human gastric tissue.
5
13 12
14 47
15
Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays
2
16 17
17 49
18 12
19 57
20 21

About Zeki Topçu

Zeki Topçu is a scholar working on Aging, Toxicology and Pharmacology, having authored 33 papers that have together received 596 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (13 papers), Synthesis and biological activity (8 papers) and Bioactive Compounds and Antitumor Agents (4 papers). The work is most often cited by research in Toxicology (57 citations), Aging (25 citations) and Organic Chemistry (218 citations). Zeki Topçu has collaborated with scholars based in Türkiye, United States and Hungary. Frequent co-authors include Sevil Zencir, István Zupkó, Borbála Réthy, Katherine L. B. Borden, David L. Mack, Robert Hromas, Michael J. McEachern, Frank J. Castora, Halise İnci Gül and Mustafa Gül. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026